Is This Elon's Worst Nightmare?

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

Regeneron Pharmaceuticals, Inc
NASDAQ:REGN
$560
Open 567.34 Prev Close 568.20
High 570.00 Low 559.45
Volume 602,753 Volume (Avg) 993
52 Week High 1,160.87 52 Week Low 475.77
Market Cap 59.4B PE Ratio 14.11

General

NameRegeneron Pharmaceuticals, Inc
TickerREGN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees15,182

About Regeneron Pharmaceuticals, Inc

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia (HoFH) or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; Evkeeza for treatment of HoFH; Ordspono for Follicular lymphoma and Diffuse large B-cell lymphoma; and Veopoz for CD55-deficient protein-losing enteropathy. Further, it develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types; and with Sonoma Biotherapeutics, Inc. to discover, develop, and commercialize engineered regulatory T cell therapies. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Highlights

Analyst Target727.87
Market Cap59,353,000,000
PE Ratio14.11
PEG Ratio1.08
EBITDA4,466,800,128

Valuation

Trailing PE14.11
Forward PE14.43
Price/Sales (Trailing 12 Mt.)4.18
Price/Book (Most Recent Quarter)1.98

Technicals

Beta0.31
52 Week High1,160.87
52 Week Low475.77
50 Day Average-0.70%
200 Day Average-9.96%

Dividend

Regeneron Pharmaceuticals, Inc pays out a dividend of $2.98 per share, with a dividend yield of 0.53%.

REGN's last dividend payment was made to shareholders on September 3, 2025.

They pay out 0.00% of their earnings out as a dividend.

Recent Dividends

Sep 3, 2025$0.88
Jun 6, 2025$0.88
Mar 20, 2025$0.88
Most Popular

Apple deepens its ties to a Kentucky plant that produces cover glass for iPhone and Apple Watch

HARRODSBURG, Ky. (AP) — Apple is putting its trust in a Kentucky plant singled out to become the exclusive producer of the cover glass meant to safeguard every iPhone and Apple Watch sold worldwide by the tech giant.

South Korea president says Korean companies will hesitate to invest in US without better visa system

SEOUL, South Korea (AP) — South Korea’s president said Thursday that South Korean companies will likely hesitate to maintain or make direct investments in the United States if the U.S. fails to for Korean workers.

Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad

The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.

Vince Stock Flies After Q2 Earnings: Here's What To Know

Vince shares soar on heavy volume after the company reported better-than-expected Q2 results.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before Oct 16's bombshell.

Powerball jackpot rises to an estimated $1.3 billion after no winning ticket sold

DES MOINES, Iowa (AP) — The Powerball jackpot rose to an estimated $1.3 billion Monday night after the winning numbers failed to appear.

NextEra Energy Eyes A Nuclear Revival

NextEra Energy plans to bring the Duane Arnold nuclear plant back online as major tech companies seek more nuclear energy.

October 16 Changes the Microchip Game - and Investing - Ad

George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar.

What's Going On With Dell Stock Thursday?

Dell Technologies Inc. (NYSE:DELL) is in the spotlight Thursday ahead of its second quarter earnings report today after the market closes.

Elon Musk in line for $1 trillion pay package if Tesla hits aggressive goals over next 10 years

could be in line for a payout of $1 trillion if his electric car company meets a series of extremely aggressive targets over the next 10 years, according to documents released by the company.

Could You Use Some Instant Cash Upfront? - Ad

Millionaire trader Jeff Clark's #1 income strategy gives you the chance to collect instant cash payouts, as much as $100 to $1,000 upfront! The great part is you can collect these upfront cash payouts without owning a single stock.... Jeff's put all the details in a special briefing titled Infinite Income Manifesto.

Super Micro Computer (SMCI) Shares Are Sliding Tuesday: What's Going On?

Super Micro Computer shares are trading lower Tuesday. The stock is caught in a downdraft affecting the broader semiconductor and high-growth technology sectors.

Von der Leyen proposes bolder EU sanctions against Israel over the war in Gaza

ANTWERP, Belgium (AP) — European Commission President Ursula von der Leyen broke Wednesday with her pro-Israel stance and announced plans to seek sanctions and a partial trade suspension against Israel over .

Trump's $5.3 Trillion "Manhattan Project" - Ad

Trump just launched a $5.3T AI-powered missile shield-America's modern "Manhattan Project." While defense giants scramble, one tiny firm is already 40x smaller than Lockheed... yet leads anti-drone tech in 300+ defense programs. With $1.3B in contracts, this stock could soar.

Takeaways from a hunt for 'secret' fresh water under the North Atlantic seabed

ABOARD LIFTBOAT ROBERT, North Atlantic (AP) — It turns out the Continental Shelf has been holding a secret from the ages. Beneath the sea floor off the U.S. northeast lies an enormous reserve of fresh water whose existence was long unknown, then was suspected and now is confirmed.

OpenAI To Mass-Produce 1st Proprietary AI Chip With Broadcom, Secures $10 Billion Deal: Report

OpenAI is set to begin mass production of its first proprietary artificial intelligence chip next year through a partnership with Broadcom.

The New Way to Use AI in the Stock Market... - Ad

A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took dozens of technology and finance experts, including one PhD astrophysicist, and $4 million in total research costs). In a multi-year backtest, this breakthrough beat stocks, bonds, gold... even Warren Buffett.

Trump Admin Pushes G7, EU To Slap Tariffs On China And India Over Russian Oil Purchase To 'End The Senseless Killing' In Ukraine

The U.S. is pressing G7 and EU allies to impose tariffs on China and India for buying Russian oil, while Trump's trade war policies have driven tariff revenues to a record $30 billion in August.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Israel launches a satellite to expand its surveillance capability throughout Middle East

JERUSALEM (AP) — Israel has launched a new spy satellite that defense officials described as a strategic cornerstone, saying it will strengthen their surveillance capacity across the Middle East in the years ahead.

Inside Warren Buffett's Decision to Keep Leading Berkshire Hathaway in His 90s

Warren Buffett's retirement decision has sparked debates about his reasons for working past the typical retirement age and his current choice to step aside.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the October 1st funding window closes.

South Korean workers detained in immigration raid headed to Atlanta for flight home

ATLANTA (AP) — Buses carrying workers from South Korea who were detained last week in an immigration raid at a battery factory were traveling Thursday from a detention center in southeast Georgia to Atlanta, where a charter plane was waiting to take them home.

Girls fell behind boys in math during the pandemic. Schools are trying to make up lost ground

IRVING, Texas (AP) — Crowded around a workshop table, four girls at de Zavala Middle School puzzled over a Lego machine they had built. As they flashed a purple card in front of a light sensor, nothing happened.

Stanley Druckenmiller and Nvidia Just Piled Into This Obscure Startup - Ad

Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend - twice featured on 60 Minutes - predicts that "Amazon Helios" will be bigger than all of those... COMBINED.

Bill Ackman Promises $1 Million Fund To Support Charlie Kirk's Family And Matches Contribution To Help FBI Catch His Killer

Following the assassination of conservative political activist Charlie Kirk, billionaire investor Bill Ackman has pledged to create a $1 million endowment for Kirk's family alongside a contribution to FBI reward.

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

Enovix Stock Tumbles After Hours: What To Know

Enovix shares are down after the company announced the offering of $300 million in convertible senior notes.

Marjorie Taylor Greene Put Money In BlackRock's Bitcoin ETF This Year — Here's How Her Returns Stack Up Against Others In Congress

Rep. Marjorie Taylor Greene (R-Ga.) has added considerable Bitcoin (CRYPTO: BTC) exposure to her investment portfolio in 2025, making strategic purchases into iShares Bitcoin Trust ETF (NASDAQ:IBIT).

Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad

The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.

Mystery surrounds $1.2 billion Army contract to build huge detention tent camp in Texas desert

WASHINGTON (AP) — When last month awarded a contract worth up to $1.2 billion to build and operate what it says will become , it didn’t turn to a large government contractor or even a firm that specializes in private prisons.

Trump Ends De-Minimis Exemptions To All Countries: How This Will Impact Your Online Shopping

President Donald Trump's executive order, which ends de minimis exemptions, is set to take effect on Friday. This will effectively close the duty-free shipping loophole that allowed small commercial packages worth $800 or less to enter the United States without being subject to taxes or tariffs.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before Oct 16's bombshell.

October 16 Changes the Microchip Game - and Investing - Ad

George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar.

Eightco, Nebius, Quantumscape, Planet Labs And Globalstar: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average up 0.25% at 45,514.95, the S&P 500 advancing 0.2% to 6,495.15, and the Nasdaq climbing 0.45% to 21,798.69. These are the top stocks that gained the attention of retail traders and investors throughout the day.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service